Entity
  • Standard BioTools

    Created in 1999
  • BETA

    Trend leader (A+)
    Existing signals make this entity one of the most dynamic startups
  • Social networks

    7,021 7,009 32,059
  • Activities

  • Technologies

  • Entity types

  • Location

    2 Tower Pl Suite 2000, South San Francisco, CA 94080, USA

    South San Francisco

    United States of America

  • Employees

    Scale: 501-1000

    Estimated: 965

  • Engaged corporates

    6
    1 6
  • Added in Motherbase

    3 years, 2 months ago
Description
  • Value proposition

    Providing essential, standardized tools to accelerate breakthroughs in human health
    Microfluidics | Cytometry | Imaging

    Fluidigm is now Standard BioTools.
    A company and a name that reflects our commitment to you and your research ...
    To unleash the power of essential, standardized tools that help the life science industry develop breakthrough medicines faster and better.

    We are evolving to better meet the needs of our customers, bridging a robust and established portfolio of next-generation technologies with an experienced team of leaders dedicated to operational excellence.

    Standard BioTools – Unleashing reliable tools to accelerate breakthroughs in human health

    • Providing trusted and repeatable insights that transform scientific discoveries into better outcomes
    • Improving operating systems through more focused, methodical and consistent processes and an emphasis on quality
    • Delivering important value to our customers and their research

    Mass Cytometry, Tissue Imaging, NGS Library Prep, Genotyping, Gene Expression, Copy Number Variation, Real-Time PCR, and Single-Cell Genomics

  • Standard BioTools | Standard BioTools

    We support the scientific community in the quest to solve unanswered challenges in health and disease across basic, translational and clinical research, including the fields of cancer, inflammatory diseases, immunotherapies and environmental monitoring. Harnessing the power of proprietary CyTOF® and microfluidics technologies, Fluidigm products provide comprehensive cell analysis aimed to elevate scientific data into actionable insights.

  • https://www.standardbio.com/
Corporate interactions BETA
Corporate TypeTweets Articles
Novartis
Novartis
Pharmaceutical, Pharmaceutical Manufacturing
Novartis
Pharmaceutical, Pharmaceutical Manufacturing
Not capitalistic
Not partnership
Event

18 Apr 2016


AstraZeneca
AstraZeneca
Pharmaceutical, Pharmaceutical Manufacturing
AstraZeneca
Pharmaceutical, Pharmaceutical Manufacturing
Other

9 May 2021


European Bioinformatics Institute | EMBL-EBI
European Bioinformatics Institute | EMBL-EBI
Research, Software Development
European Bioinformatics Institute | EMBL-EBI
Research, Software Development
Not capitalistic
Not partnership
Event

25 May 2016


Illumina For Startups
Illumina For Startups
Startup accelerator & VC, Biotechnology, Biotechnology Research
Illumina For Startups
Startup accelerator & VC, Biotechnology, Biotechnology Research
Other

26 May 2020


Genopole
Genopole
Biotechnology, Biotechnology Research
Genopole
Biotechnology, Biotechnology Research
Not capitalistic
Not partnership
Event

5 May 2019


Nasdaq
Nasdaq
Finance, Financial Services
Nasdaq
Finance, Financial Services
Other

20 Apr 2022


Similar entities
Loading...
Loading...
Social network dynamics